Profil
Kari Myren is currently Chief Medical Officer at Oncoinvent ASA since 2021.
Former positions include Non-Executive Director at SoftOx Solutions AS, VP-Global Medical Affairs & Clinical Development at Photocure ASA from 2019 to 2021, and Chief Medical Officer at Oncoinvent ASA (Old).
Education includes an undergraduate degree from the University of Oslo.
Aktive Positionen von Kari Myren
| Unternehmen | Position | Beginn |
|---|---|---|
| ONCOINVENT ASA | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2021 |
Ehemalige bekannte Positionen von Kari Myren
| Unternehmen | Position | Ende |
|---|---|---|
| SOFTOX SOLUTIONS | Direktor/Vorstandsmitglied | 24.03.2023 |
| PHOTOCURE ASA | Technik-/Wissenschafts-/F&E-Leiter | 01.10.2021 |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Kari Myren
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Photocure ASA
Photocure ASA Medical SpecialtiesHealth Technology Develops and sells pharmaceuticals and medical devices | Health Technology |
University of Oslo
University of Oslo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BerGenBio ASA
BerGenBio ASA Pharmaceuticals: MajorHealth Technology Develops drugs for aggressive, drug resistant cancers | Health Technology |
Oncoinvent AS
Oncoinvent AS Pharmaceuticals: MajorHealth Technology Develops alpha-emitting radiopharmaceuticals for cancer treatment | Health Technology |
SoftOx Solutions AS
SoftOx Solutions AS Miscellaneous Commercial ServicesCommercial Services Develops and manufactures non-toxic & antiseptic medicines | Commercial Services |
















